StockData
GT Biopharma, Inc. logo

GT Biopharma, Inc. (GTBP) stock

GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$3.43+0.25 (+7.86%)

Close on Nov 18, 2026Market cap $154.73MP/E –Yield –

GT Biopharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

GT Biopharma's price to book ratio was 17.4× on Nov 11, 2026, against 39.8× a year earlier. Over the last 5 years it ranged from 13.9× to 481.8×, with a median of 45.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202617.4×−22.2
2025Dec 31, 202539.6×−41.6
2024Dec 31, 202481.2×+54.8
2023Dec 29, 202326.4×−18.9
2022Dec 30, 202245.3×−377.2
2019Oct 31, 2019422.6×+292.7
2018Oct 31, 2018129.9×−241.2
2017Dec 29, 2017371.0×–

More GT Biopharma figures

See a number that looks wrong?